Market Tracker

12/15 5:15pm ET

Corcept Therapeutics Inc (NASDAQ:CORT)

16.61
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
6.70
Today|||52-Week Range
20.77
+128.79%
Year-to-Date
Shire's New Formulation of Oncaspar Gets Approval in Europe
Dec 14 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets FDA Priority Review for Rare Lymphoma
Dec 12 / Zacks.com - Paid Partner Content
Regeneron, Sanofi Report Positive Top Line Skin Cancer Data
Dec 13 / Zacks.com - Paid Partner Content
Spark Therapeutics Stock Plunges on Hemophilia Therapy Data
Dec 12 / Zacks.com - Paid Partner Content
Allergan Inks Deal to Buy Texas-Based Repros Therapeutics
Dec 13 / Zacks.com - Paid Partner Content
Lilly Reports Mixed Results from Late-Stage Cyramza Study
Dec 11 / Zacks.com - Paid Partner Content
Proteostasis Stock Surges on Positive Data From CF Studies
Dec 13 / Zacks.com - Paid Partner Content
Roche Reports Tecentriq/Avastin Lung Cancer Study Data
Dec 07 / Zacks.com - Paid Partner Content
Glaxo's Nucala Label Expansion Application Gets FDA Approval
Dec 13 / Zacks.com - Paid Partner Content
Revance's Neuromodulator Injection Positive in Phase III
Dec 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close16.61
Today’s open17.31
Day’s range16.10 - 17.43
Volume2,283,145
Average volume (3 months)1,431,089
Market cap$1.9B
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+503.57%
Earnings growth (next 5 years)+49.29%
Revenue growth (last year)+61.72%
P/E ratio57.3
Price/Sales9.87
Price/Book45.24

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...0.000.00%
TBPHTheravance Biopharma...0.000.00%
CBMCambrex Corp0.000.00%
AERIAerie Pharmaceutical...0.000.00%
Data as of 4:03pm ET, 12/15/2017

Financials

Next reporting dateFebruary 13, 2018
EPS forecast (this quarter)$0.17
Annual revenue (last year)$81.3M
Annual profit (last year)$8.1M
Net profit margin10.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer, Director &
MD
Joseph K. Belanoff
Secretary &
Chief Financial Officer
Gary Charles Robb
Corporate headquarters
Menlo Park, California

Forecasts